These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38329558)

  • 21. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
    Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B;
    AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
    Rodger AJ; Cambiano V; Bruun T; Vernazza P; Collins S; Degen O; Corbelli GM; Estrada V; Geretti AM; Beloukas A; Raben D; Coll P; Antinori A; Nwokolo N; Rieger A; Prins JM; Blaxhult A; Weber R; Van Eeden A; Brockmeyer NH; Clarke A; Del Romero Guerrero J; Raffi F; Bogner JR; Wandeler G; Gerstoft J; Gutiérrez F; Brinkman K; Kitchen M; Ostergaard L; Leon A; Ristola M; Jessen H; Stellbrink HJ; Phillips AN; Lundgren J;
    Lancet; 2019 Jun; 393(10189):2428-2438. PubMed ID: 31056293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "It comes altogether as one:" perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States.
    Campbell DM; Dubé K; Cowlings PD; Dionicio P; Tam RM; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
    BMC Public Health; 2022 Jul; 22(1):1317. PubMed ID: 35810288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences Between Groups of Pre-exposure Prophylaxis (PrEP) Using Couples in HIV-Negative/Unknown Relationships.
    John SA; Robles G; Starks TJ; Rendina HJ
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):419-428. PubMed ID: 30985555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
    Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
    Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rates of Pre-exposure Prophylaxis Use and Discontinuation Among a Large U.S. National Sample of Sexual Minority Men and Adolescents.
    Whitfield THF; Parsons JT; Rendina HJ
    Arch Sex Behav; 2020 Jan; 49(1):103-112. PubMed ID: 31845148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Condom use likelihood within the context of PrEP and TasP among men who have sex with men in Florida: a short report.
    Algarin AB; Shrader CH; Hackworth BT; Ibanez GE
    AIDS Care; 2022 Mar; 34(3):294-300. PubMed ID: 33565330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reported preexposure prophylaxis use among male sex partners of HIV-positive men: 2016-2018.
    Beer L; Tie Y; Smith DK; Fagan JL; Shouse RL;
    AIDS; 2020 Jun; 34(7):1081-1087. PubMed ID: 32167972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Talking to My Partners About PrEP: Factors Associated with PrEP-Related Communication in a Longitudinal US Study of Sexual Minority Men Living with HIV.
    Walsh JL; John SA; Robles G; Wesche R; Hirshfield S
    Prev Sci; 2022 Nov; 23(8):1438-1447. PubMed ID: 35524930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples.
    Hoff CC; Chakravarty D; Bircher AE; Campbell CK; Grisham K; Neilands TB; Wilson PA; Dworkin S
    AIDS Patient Care STDS; 2015 Jul; 29(7):408-17. PubMed ID: 26057304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study.
    John SA; Sizemore KM; Jimenez RH; Jones SS; Petroll AE; Rendina HJ
    JMIR Public Health Surveill; 2022 Dec; 8(12):e31237. PubMed ID: 36306518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of preexposure prophylaxis and condom purchasing decisions.
    Gebru NM; Strickland JC; Reed DD; Kahler CW; Leeman RF
    J Exp Anal Behav; 2024 Mar; 121(2):233-245. PubMed ID: 38356347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What are the situational and behavioral factors associated with condomless anal sex without pre-exposure prophylaxis in MSM?
    Di Ciaccio M; Sagaon-Teyssier L; Mimi M; Suzan-Monti M; Protiere C; Castro DR; Meyer L; Tremblay C; Chidiac C; Capitant C; Préau M; Molina JM; Spire B;
    AIDS; 2020 Jul; 34(9):1367-1375. PubMed ID: 32287072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.
    Zimmermann HML; Jongen VW; Boyd A; Hoornenborg E; Prins M; de Vries HJC; Schim van der Loeff MF; Davidovich U;
    AIDS; 2020 Dec; 34(15):2295-2304. PubMed ID: 33196494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Behavioral Economic Examination of Sexual Behaviors in the Era of Pre-exposure Prophylaxis via Explanatory Sequential Mixed Methods.
    Gebru NM; James TG; Ahn S; Cheong J; Berry MS; Cook RL; Leeman RF
    Arch Sex Behav; 2024 Apr; 53(4):1541-1559. PubMed ID: 38472604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "What other choices might I have made?": Sexual Minority Men, the PrEP Cascade and the Shifting Subjective Dimensions of HIV Risk.
    Gaspar M; Wells A; Hull M; Tan DHS; Lachowsky N; Grace D
    Qual Health Res; 2022 Jul; 32(8-9):1315-1327. PubMed ID: 35616240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
    Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C;
    BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Behavioral Cascade of HIV Seroadaptation Among US Men Who Have Sex with Men in the Era of PrEP and U = U.
    Goodreau SM; Maloney KM; Sanchez TH; Morris M; Janulis P; Jenness SM
    AIDS Behav; 2021 Dec; 25(12):3933-3943. PubMed ID: 33884510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blue-Ribbon Boys: factors associated with PrEP use, ART use and undetectable viral load among gay app users across six regions of the world.
    Ayala G; Santos GM; Arreola S; Garner A; Makofane K; Howell S
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25130. PubMed ID: 30033536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.